Rabbit Anti-IMP3 Recombinant Antibody (CBYY-I0526) (CBMAB-I1200-YY)

Martin-Morales, N., Padial-Molina, M., Tovar, I., De Araujo Farias, V., Hernández-Cortés, P., Ramirez-Moreno, E., ... & O’Valle Ravassa, F. J. (2023). IMP3 immunohistochemical expression is related with progression and metastases in xenografted and cutaneous melanomas. Pathobiology: Journal of Immunopathology, Molecular and Cellular Biology.

Khashman, B. M., Alwandawi, T. K., & Al-Jussani, G. N. (2022). Evaluation of Insulin-like Growth Factor II Mrna Binding Protein 3 (IMP3) Expression in A Group of Iraqi Women with Breast Cancer. HIV Nursing, 22(2), 471-473.

Albericio, G., Aguilar, S., Torán, J. L., Yañez, R., López, J. A., Vázquez, J., ... & Bernad, A. (2021). Comparative Proteomic Analysis of Nuclear and Cytoplasmic Compartments in Human Cardiac Progenitor Cells. Functional Evaluation of IL1A and IMP3.

Sweeney, J., Rao, R., Margolskee, E., Goyal, A., Heymann, J. J., & Siddiqui, M. T. (2018). Immunohistochemical staining for S100P, SMAD4, and IMP3 on cell block preparations is sensitive and highly specific for pancreatic ductal adenocarcinoma. Journal of the American Society of Cytopathology, 7(6), 318-323.

Burdelski, C., Jakani-Karimi, N., Jacobsen, F., Möller-Koop, C., Minner, S., Simon, R., ... & Wilczak, W. (2018). IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues. Oncology reports, 39(1), 3-12.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols